Memory Disorders Center

A team of neurologists, psychiatrists, neuropsychologists, and other health-care professionals specially trained in diagnosing and treating memory disorders will perform evaluations for patients experiencing memory loss.

Diagnosing dementia is not done with a single test. During our free memory evaluations, the work up may consist of an MRI of the Brain, laboratory tests and neuropsychological testing. However, each patient is treated individually and medical work ups will vary depending on the patient's past medical history and clinical presentation.

Once the evaluation for the patient has been completed, this multidisciplinary team will discuss the findings with the patient and/or family and formulate a treatment and management plan with one of our experienced psychiatrists. Patients will continue to be followed on a regular basis in the clinic based on their condition, clinical need, and their participation in research studies.

The team offers participation in a variety of research studies. These include investigational treatment studies for mild cognitive impairment and Alzheimer's disease, brain imaging studies utilizing MRI and PET scanning with state-of-the-art techniques and new radioactive tracers, genetic and family studies involving specific risk factors, and new approaches to make an early diagnosis of Alzheimer's disease. The Memory Disorders Center is the main clinical component of the Columbia University Alzheimer's Disease Research Center (ADRC), and is one of 28 specialized ADRCs funded by the National Institute on Aging, which is part of the National Institutes of Health (NIH).


Jessica D'Antonio: (646) 774-8674


A telephone screening will determine if a patient is eligible for an evaluation, however, all patients must be over the age of 55.


Family members, friends, and physicians may refer patients to the Center.

Financial Information

Although the evaluation by the physician and neuropsychologist are free of charge, the medical work-up is the financial responsibility of the patient (i.e. medical insurance).

Current Clinical Trails

  • Olfactory Deficits and Donepezil Treatment in Cognitively Impaired Elderly
  • Treatment of Psychosis and Agitation in Alzheimer's Disease
  • Cognitive Training and Neuroplasticity in Mild Cognitive Impairment 
  • Anti-Viral Therapy in Alzheimer's Disease 
  • Escitalopram for Agitation in Alzheimer's Disease

Principal Investigators

Core Faculty